30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Rajeev Shah

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -34% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Satsuma Pharmaceuticals Inc None -
Director Kalvista Pharmaceuticals Inc Nov. 21, 2016 - April 16, 2018
Rajeev Shah's trades of KALA BIO Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-03-13 2020-03-13
US KALA BIO Inc (KALA)
B Purchase
43,221 -0.5%
138.69
US$1,867,881 		43,221 -0.5% 138.69 US$1,867,881
2020-02-05 2020-02-03
B Purchase
20,759 +40.5%
412.91
US$743,693 		20,759 +40.5% 412.91 US$743,693
2020-02-05 2020-02-03
B Purchase
19,262 -3.7%
348.50
US$3,771,944 		19,262 -3.7% 348.50 US$3,771,944
2020-02-05 2020-02-03
B Purchase
785,658 +69.0%
19.00
US$14,927,502 		785,658 +69.0% 19.00 US$14,927,502
2019-09-17 2019-09-17
B Purchase
192,387 +4.3%
15.00
US$2,885,805 		192,387 +4.3% 15.00 US$2,885,805
2019-09-17 2019-09-17
B Purchase
1,140,946 +34.1%
15.00
US$17,114,190 		1,140,946 +34.1% 15.00 US$17,114,190